CD133-targeted afatinib nanomicelles for enhanced lung cancer theranostics.
Leng D, Cao K, Hao Q, Peng Z, Pan G, Liu J, Yu J, Tang J, Li J, Chen H, Chen H, Tang H.
Leng D, et al. Among authors: liu j.
Nanomedicine (Lond). 2024;19(30):2605-2617. doi: 10.1080/17435889.2024.2422804. Epub 2024 Nov 27.
Nanomedicine (Lond). 2024.
PMID: 39601387